In summary, our data support the conclusion that host MSLN expression plays a vital role in priming the tumor naïve peritoneal microenvironment consequently contributing to the progression of ovarian cancer metastasis, as deletion of host MSLN expression decreases the size of heterogeneous multicellular aggregates and ovarian cancer metastatic burden. The gene discussed is MSLN; the disease is ovarian carcinoma.